Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study

Journal of Clinical Oncology

Volumn 24, Issue 4, 2006, Pages 612-618

  Lee, Jeeyun ^b   Suh, Cheolwon ^b   Yeon, Hee Park ^b   Ko, Young H ^b   Soo, Mee Bang ^b   Jae, Hoon Lee ^b   Dae, Ho Lee ^b   Huh, Jooryung ^b   Sung, Yong Oh ^b   Kwon, Hyuk Chan ^b   Hyo, Jin Kim ^b   Soon, Il Lee ^b   Jung, Han Kim ^b   Park, Jinny ^b   Seok, Joong Oh ^b   Kim, Kihyun ^b   Jung, Chulwon ^b   Park, Keunchil ^b   Won, Seog Kim ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE ESCALATION; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER T CELL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; T CELL LYMPHOMA; ANALYSIS OF VARIANCE; CANCER INVASION; CLINICAL TRIAL; CONFIDENCE INTERVAL; LYMPH NODE METASTASIS; MIDDLE AGED; MULTICENTER STUDY; NATURAL KILLER CELL; NOSE TUMOR; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; STATISTICAL MODEL; SURVIVAL;

AGED; ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KILLER CELLS, NATURAL; LYMPHATIC METASTASIS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM INVASIVENESS; NOSE NEOPLASMS; ODDS RATIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 33644843494     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.1384     Document Type: Article

References (33)

1. Jaffe ES, Harris NL, Stein H, et al: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Hematopoietic and Lymphoid Tissues. Lyon, Frances, IARC Press, 2001, pp 204-207
2. Aozasa K, Ohsawa M, Tajima K, et al: Nationwide study of lethal mid-line granuloma in Japan: Frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer 44:63-66, 1989
3. Chan JKC, Ng CS, Lau WH, et al: Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 11:418-429, 1987
4. Ferry J, Sklar J, Zukerberg L, et al: Nasal lymphoma: A clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol 15:268-779, 1991
5. Harabuchi Y, Yamanaka N, Kataura A, et al: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335:128-130, 1990
6. Ho FCS, Choy D, Loke SL, et al: Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: A clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol 21:1041-1050, 1990
7. Liang R, Todd D, Chan TK, et al: Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 13:666-670, 1995
8. Kim GE, Cho JH, Yang WI, et al: Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment. J Clin Oncol 18:54-63, 2000
9. Siu LL, Chan JK, Kwong YL: Natural killer cell malignancies: Clinicopathologic and molecular features. Histol Histopathol 17:539-554, 2002
10. Ko YH, Kim CW, Park CS, et al: REAL classification of malignant lymphomas in the Republic of Korea: Incidence of recently recognized entities and changes in clinicopathologic features. Cancer 83:806-812, 1998
11. Au WY, Ma SY, Chim CS, et al: Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: A single center experience of 10 years. Ann Oncol 16:206-214, 2005
12. Kim K, Kim WS, Jung CW, et al: Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification. Eur J Cancer 38:75-81, 2002
13. Lee J, Park YH, Kim WS, et al: Extranodal nasal type NK/T-cell lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 41:1402-1408, 2005
14. Chim CS, Ma SY, Au WY, et al: Primary nasal natural killer cell lymphoma: Long-term treatment outcome and relationship with the International Prognostic Index. Blood 103:216-221, 2004
15. Jaffe ES: Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 87:1207-1210, 1996
16. Harris NL, Jaffe ES, Diebold J, et al: World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17:3835-3849, 1999
17. Cheung MM, Chan J, Lai W, et al: Early stage nasal NK/T-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54:182-190, 2002
18. Cheung MM, Chan J, Lau W, et al: Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 16:70-77, 1998
19. Aviles A, Diaz NR, Neri N, et al: Angiocentric nasal T/natural killer cell lymphoma: A single centre study of prognostic factors in 108 patients. Clin Lab Haematol 22:215-220, 2000
20. You JY, Chi KH, Yang MH, et al: Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: A single institute survey in Taiwan. Ann Oncol 15:618-625, 2004
21. Lee J, Kim WS, Park YH, et al: Nasal-type NK/T-cell lymphoma: Clinical features and treatment outcome. Br J Cancer 92:1226-1230, 2005
22. Robbins KT, Fuller LM, Vlasak M, et al: Primary lymphomas of the nasal cavity and paranasal sinuses. Cancer 56:814-819, 1985
23. Logsdon MD, Ha CS, Kavadi VS, et al: Lymphoma of the nasal cavity and paranasal sinuses: Improved outcome and altered prognostic factors with combined modality therapy. Cancer 80:477-488, 1997
24. Li YX, Coucke PA, Li JY, et al: Primary non-Hodgkin's lymphoma of the nasal cavity: Prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer 83:449-456, 1998
25. Kim WS, Song SY, Ahn YC, et al: CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 12:349-352, 2001
26. Au WY, Pang A, Choy C, et al: Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 104:243-249, 2004
27. Cheson BD, Horning SJ, Coiffier B, et al: Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma. J Clin Oncol 17:1244-1253, 1999
28. Cox DR: Regression models and life-tables. J Stat Soc 34:187-220, 1982
29. Gallamini A, Stelitano C, Calvi R, et al: Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study. Blood 103:2474-2479, 2004
30. Solal-Céligny P, Roy P, Colombat P, et al: Follicular lymphoma international prognostic index. Blood 104:1258-1265, 2004
31. Hanson CA, Brunning RD, Gajl-Peczalska KJ, et al: Bone marrow manifestation of peripheral T-cell lymphoma: A study of 30 cases. Am J Clin Pathol 86:449-460, 1986
32. Au WY, Lie AKW, Liang R, et al: Autologous stem cell transplantation for nasal NK/T-cell lymphoma: A progress report on its value. Ann Oncol 14:1673-1679, 2003
33. E extranodal NK/T-cell lymphoma, nasal type. Blood 106:3785-3790, 2005